Ibuprofen

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instanceOf nonsteroidal anti-inflammatory drug
gptkbp:affiliatedWith propionic acid derivatives
gptkbp:ATCCode M01AE01
gptkbp:brand gptkb:Nurofen
gptkb:Motrin
gptkb:Advil
gptkbp:CASNumber 15687-27-1
gptkbp:chemicalFormula C13H18O2
gptkbp:contraindication peptic ulcer
hypersensitivity to NSAIDs
severe heart failure
gptkbp:countryOfOrigin gptkb:United_Kingdom
gptkbp:developedBy gptkb:Boots_UK
gptkbp:discoveredBy gptkb:John_Nicholson
gptkb:Stewart_Adams
gptkbp:discoveredIn 1961
gptkbp:eliminationHalfLife 2-4 hours
gptkbp:excretion urine
gptkbp:FDAApproved 1974
https://www.w3.org/2000/01/rdf-schema#label Ibuprofen
gptkbp:interactsWith gptkb:warfarin
gptkb:aspirin
gptkb:methotrexate
lithium
gptkbp:IUPACName (RS)-2-(4-(2-methylpropyl)phenyl)propanoic acid
gptkbp:KEGGID D00126
gptkbp:legalStatus over-the-counter
prescription (higher doses)
gptkbp:marketedAs 1969
gptkbp:mechanismOfAction COX inhibitor
gptkbp:meltingPoint 76°C
gptkbp:metabolism liver
gptkbp:pregnancyCategory C (US, prior to 30 weeks gestation)
D (US, after 30 weeks gestation)
gptkbp:PubChem_CID gptkb:DB01050
gptkb:CHEMBL521
3672
3546
gptkbp:riskFactor cardiovascular events (with prolonged use)
kidney damage (with prolonged use)
gptkbp:routeOfAdministration oral
topical
intravenous
gptkbp:sideEffect nausea
dizziness
headache
gastrointestinal upset
increased risk of bleeding
gptkbp:solubility poor
gptkbp:UNII WK2XYI10QM
gptkbp:usedFor pain relief
fever reduction
inflammation reduction
gptkbp:WHOModelListOfEssentialMedicines yes
gptkbp:bfsParent gptkb:Domestic_cats
gptkbp:bfsLayer 6